-
1
SeaBeLife has appointed Professor Eric Souied to its scientific committee.
-
2
Focus on age-related macular degeneration (AMD) and retinal diseases.
-
3
Souied will guide programs targeting necroptosis and ferroptosis.
-
4
He has published over 650 scientific works.
-
5
SBL03 is the lead candidate against geographic atrophy.
-
6
AMD affects 8 million currently; expected to reach 10 million by
-
7
The company aims to address the underlying causes of degeneration.
Original Source(s)
Eric Souied Joins SeaBeLife
French biotechnology company, SeaBeLife, welcomes AMD specialist to its scientific committee
March 9, 2026
-
2 min
Related Content
The Retina: A Window on Neurodegeneration
New evidence links Chlamydia pneumoniae to retinal inflammation patterns associated with neurodegeneration
March 9, 2026
-
7 min
Commercial Launch of OS 4 Up
Platform features newly developed Phaco Assisted Cataract Surgery (PACS) modulation
March 6, 2026
-
2 min
Debunking Myths in Eye-Brain Health
Separating hype from clinical reality in AI-powered eye–brain assessment
March 6, 2026
-
6 min
